Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction
2025 · The Oncologist · 8 citations
https://doi.org/10.1093/oncolo/oyae323
G
Gayle Jameson
HonorHealth(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
3.5K
Citations
23
h-index
35
i10-index
Gayle Jameson is an academic researcher from HonorHealth. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Cancer Treatment and Pharmacology. The author has an h-index of 23, co-authored 117 publications.
ORCID: 0000-0003-0987-5965Papers by this author
worksExosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma
2025 · British Journal of Cancer · 1 citations
https://doi.org/10.1038/s41416-025-03167-2
Supplementary Material for: Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.3808179.v1
Additional file 3 of Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13018228
Supplementary Material for: Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.3808179
Additional file 2 of Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13018225
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat